I am a computational medical scientist and entrepreneur. I believe in technology built with purpose, and in community. Together they can bring medicines to more people.
Science Spotlight: RNA medicines in the age of AI: reaching the rare
Aida is founder and CEO of Enactium Biosciences. She holds a PhD from Imperial College London (MRC Laboratory of Medical Sciences), followed by a research fellowship at Duke-NUS Medical School in Singapore. Her experience spans multiple disease areas and technology modalities, with deep expertise in omics, computational modelling, target discovery, cell and gene therapy. She was previously Cell Informatics R&D Director at the TechBio company Mogrify in Cambridge, UK.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |